Loading clinical trials...
Loading clinical trials...
A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (FERWON-IDA)
Conditions
Interventions
Iron isomaltoside/ferric derisomaltose
Iron sucrose
Locations
114
United States
Pharmacosmos Investigational Site
Birmingham, Alabama, United States
Pharmacosmos Investigational Site
Dothan, Alabama, United States
Pharmacosmos Investigational Site
Guntersville, Alabama, United States
Pharmacosmos Investigational Site
Phoenix, Arizona, United States
Pharmacosmos Investigational Site
Little Rock, Arkansas, United States
Pharmacosmos Investigational Site
Little Rock, Arkansas, United States
Start Date
November 8, 2016
Primary Completion Date
March 28, 2018
Completion Date
March 28, 2018
Last Updated
October 6, 2020
NCT05251493
NCT05836961
NCT06642337
NCT06631612
NCT07394088
NCT06238895
Lead Sponsor
Pharmacosmos A/S
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions